Cargando…

Seizure control in patients with epilepsy: the physician vs. medication factors

BACKGROUND: Little is known about the relationship between types of healthcare providers and outcomes in patients with epilepsy. This study compares the relative effects of provider type (epileptologist vs. other neurologist) and pharmacologic treatment (newer vs. older antiepileptic drugs) on seizu...

Descripción completa

Detalles Bibliográficos
Autores principales: Szaflarski, Jerzy P, Rackley, Angela Y, Lindsell, Christopher J, Szaflarski, Magdalena, Yates, Stephen L
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2642800/
https://www.ncbi.nlm.nih.gov/pubmed/19094222
http://dx.doi.org/10.1186/1472-6963-8-264
_version_ 1782164655566749696
author Szaflarski, Jerzy P
Rackley, Angela Y
Lindsell, Christopher J
Szaflarski, Magdalena
Yates, Stephen L
author_facet Szaflarski, Jerzy P
Rackley, Angela Y
Lindsell, Christopher J
Szaflarski, Magdalena
Yates, Stephen L
author_sort Szaflarski, Jerzy P
collection PubMed
description BACKGROUND: Little is known about the relationship between types of healthcare providers and outcomes in patients with epilepsy. This study compares the relative effects of provider type (epileptologist vs. other neurologist) and pharmacologic treatment (newer vs. older antiepileptic drugs) on seizure control in patients with epilepsy. METHODS: We conducted a retrospective study of patients with medication-resistant epilepsy. Consecutive charts of 200 patients were abstracted using a standard case report form. For each patient, data included seizure frequency and medication use prior to, and while being treated by an epileptologist. Changes in seizure frequency were modeled using a generalized linear model. RESULTS: After transferring care from a general neurologist to specialized epilepsy center, patients experienced fewer seizures (p < 0.001) and were more frequently seizure-free (p < 0.001). The improved seizure control was not related to treatment with newer vs. older antiepileptic drugs (p = 0.305). CONCLUSION: Our findings suggest an association between subspecialty epilepsy care and improved seizure control in patients with medication-resistant epilepsy. Further research should prospectively determine whether patients with medication-resistant epilepsy would benefit from being routinely referred to an epilepsy specialist.
format Text
id pubmed-2642800
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-26428002009-02-14 Seizure control in patients with epilepsy: the physician vs. medication factors Szaflarski, Jerzy P Rackley, Angela Y Lindsell, Christopher J Szaflarski, Magdalena Yates, Stephen L BMC Health Serv Res Research Article BACKGROUND: Little is known about the relationship between types of healthcare providers and outcomes in patients with epilepsy. This study compares the relative effects of provider type (epileptologist vs. other neurologist) and pharmacologic treatment (newer vs. older antiepileptic drugs) on seizure control in patients with epilepsy. METHODS: We conducted a retrospective study of patients with medication-resistant epilepsy. Consecutive charts of 200 patients were abstracted using a standard case report form. For each patient, data included seizure frequency and medication use prior to, and while being treated by an epileptologist. Changes in seizure frequency were modeled using a generalized linear model. RESULTS: After transferring care from a general neurologist to specialized epilepsy center, patients experienced fewer seizures (p < 0.001) and were more frequently seizure-free (p < 0.001). The improved seizure control was not related to treatment with newer vs. older antiepileptic drugs (p = 0.305). CONCLUSION: Our findings suggest an association between subspecialty epilepsy care and improved seizure control in patients with medication-resistant epilepsy. Further research should prospectively determine whether patients with medication-resistant epilepsy would benefit from being routinely referred to an epilepsy specialist. BioMed Central 2008-12-18 /pmc/articles/PMC2642800/ /pubmed/19094222 http://dx.doi.org/10.1186/1472-6963-8-264 Text en Copyright ©2008 Szaflarski et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Szaflarski, Jerzy P
Rackley, Angela Y
Lindsell, Christopher J
Szaflarski, Magdalena
Yates, Stephen L
Seizure control in patients with epilepsy: the physician vs. medication factors
title Seizure control in patients with epilepsy: the physician vs. medication factors
title_full Seizure control in patients with epilepsy: the physician vs. medication factors
title_fullStr Seizure control in patients with epilepsy: the physician vs. medication factors
title_full_unstemmed Seizure control in patients with epilepsy: the physician vs. medication factors
title_short Seizure control in patients with epilepsy: the physician vs. medication factors
title_sort seizure control in patients with epilepsy: the physician vs. medication factors
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2642800/
https://www.ncbi.nlm.nih.gov/pubmed/19094222
http://dx.doi.org/10.1186/1472-6963-8-264
work_keys_str_mv AT szaflarskijerzyp seizurecontrolinpatientswithepilepsythephysicianvsmedicationfactors
AT rackleyangelay seizurecontrolinpatientswithepilepsythephysicianvsmedicationfactors
AT lindsellchristopherj seizurecontrolinpatientswithepilepsythephysicianvsmedicationfactors
AT szaflarskimagdalena seizurecontrolinpatientswithepilepsythephysicianvsmedicationfactors
AT yatesstephenl seizurecontrolinpatientswithepilepsythephysicianvsmedicationfactors